Skip to main content
Reata Pharmaceuticals has been acquired by Biogen. Please visit
www.biogen.com
for more information.
Site Search
Search query
About Us
Leadership
Ethics & Compliance
Our Science
Our Technologies
Nrf2 Activators
HSP90 Modulators
Pipeline
Partnering & In-Licensing
Diseases We Target
Neurology
Friedreich's Ataxia
Diabetic Peripheral Neuropathic Pain
Product
Prescribing Information
Vermont’s Pharmaceutical Marketer Price Disclosure (short form)
Vermont’s Pharmaceutical Marketer Price Disclosure (long form)
Our Community
Patient Advocacy
Clinical Trials
Early Access
Investors
Overview
News
Events & Presentations
Financials
Quarterly Results
Annual Reports
SEC Filings
ESG
ESG Overview
Environmental
Social
Governance
Documents & Charters
Committee Composition
Contact the Board
Annual Meeting
Settlement
Customizable Email Alerts
Careers
Contact Us
Locations
About Us
Leadership
Ethics & Compliance
Our Science
Our Technologies
Nrf2 Activators
HSP90 Modulators
Pipeline
Partnering & In-Licensing
Diseases We Target
Neurology
Friedreich's Ataxia
Diabetic Peripheral Neuropathic Pain
Product
Prescribing Information
Vermont’s Pharmaceutical Marketer Price Disclosure (short form)
Vermont’s Pharmaceutical Marketer Price Disclosure (long form)
Our Community
Patient Advocacy
Clinical Trials
Early Access
Investors
Overview
News
Events & Presentations
Financials
Quarterly Results
Annual Reports
SEC Filings
ESG
ESG Overview
Environmental
Social
Governance
Documents & Charters
Committee Composition
Contact the Board
Annual Meeting
Settlement
Customizable Email Alerts
Careers
Contact Us
Locations
Twitter opens in a new window
Linkedin opens in a new window
Facebook opens in a new window
Instagram opens in a new window
Site Map
About Us
Leadership
Ethics & Compliance
Our Science
Our Technologies
Nrf2 Activators
HSP90 Modulators
Pipeline
Partnering & In-Licensing
Diseases We Target
Neurology
Friedreich's Ataxia
Diabetic Peripheral Neuropathic Pain
Product
Prescribing Information
Vermont’s Pharmaceutical Marketer Price Disclosure (short form)
Vermont’s Pharmaceutical Marketer Price Disclosure (long form)
Our Community
Patient Advocacy
Clinical Trials
Early Access
Investors
Overview
News
Events & Presentations
Financials
Quarterly Results
Annual Reports
SEC Filings
ESG
ESG Overview
Environmental
Social
Governance
Documents & Charters
Committee Composition
Contact the Board
Annual Meeting
Settlement
Customizable Email Alerts
Careers
Contact Us
Locations
About Us
Leadership
Ethics & Compliance
Our Science
Our Technologies
Nrf2 Activators
HSP90 Modulators
Pipeline
Partnering & In-Licensing
Diseases We Target
Neurology
Friedreich's Ataxia
Diabetic Peripheral Neuropathic Pain
Product
Prescribing Information
Vermont’s Pharmaceutical Marketer Price Disclosure (short form)
Vermont’s Pharmaceutical Marketer Price Disclosure (long form)
Our Community
Patient Advocacy
Clinical Trials
Early Access
Investors
Overview
News
Events & Presentations
Financials
Quarterly Results
Annual Reports
SEC Filings
ESG
ESG Overview
Environmental
Social
Governance
Documents & Charters
Committee Composition
Contact the Board
Annual Meeting
Settlement
Customizable Email Alerts
Careers
Contact Us
Locations
Site Map
Legal Message
Privacy Notice
Privacy Notice - Clinical Sites
Social Media Disclosure
Contact Us